Skip to content

Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness Assessment

Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02706587
Acronym
ENS
Enrollment
102
Registered
2016-03-11
Start date
2016-03-31
Completion date
2018-06-30
Last updated
2016-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyneuropathy, Critical Illness

Keywords

Critical illness polyneuropathy, Neuromuscular Electrical Stimulation

Brief summary

The purpose of this study is to determine whether early neuromuscular electrical stimulation is effective in the prevention of neuromuscular weakness in critical ill patients.

Detailed description

Randomized, controlled study of early electrical neurostimulation (vs sham) in critically ill patients.

Interventions

DEVICENeuromuscular electrical stimulation

NEMS is delivered bilaterally to the quadriceps femoris muscle using a portable battery-powered stimulator (Rehab 400, Cefar Compex, France). The electrodes are placed on the motor points of vastus medialis and vastus lateralis muscles. Electrical stimuli of 45Hz (pulse width: 380 µseconds; 6 seconds on with 1.5 second rise time; and 0.75 seconds fall time.; 5 seconds off). The current is adjusted to ensure maximum tolerable muscle contraction The protocol is applied twice daily for 25 minutes, five days a week.

DEVICESham control

No electrostimulation

Sponsors

Fondation Paul Bennetot
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
CollaboratorOTHER
Institut Mutualiste Montsouris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patient * Aged of 18 or more * With an intended ICU stay of at least 72 hours * Mechanically ventilated

Exclusion criteria

* Age less than 18 years * Pregnant women * Preexisting neuromuscular disease * Patient bearing a pace maker or an implantable defibrillator. * Poly traumatism and/or leg fracture. * End stage disease

Design outcomes

Primary

MeasureTime frame
Medical resuscitation council (MRC) scoreup to 25 months. From date of randomization to the date of ICU discharge

Secondary

MeasureTime frameDescription
Total duration of mechanical ventilation (days)up to 25 months. From date of randomization to the date of ICU discharge
Length of ICU stay and hospital stay.up to 25 months. From date of randomization to the date of ICU discharge or hospital discharge
Type of hospital dischargeup to 25 months. From date of randomization to the date of hospital discharge(alive/deceased/rehabilitation/home...)

Countries

France

Contacts

Primary ContactChristian Lamer, MD
christian.lamer@imm.fr+33156616188
Backup ContactCeline Menez, PT
celine.menez@imm.fr+33156616134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026